Mesothelioma

Stage 3 Mesothelioma News

Lilly Acquires ImClone Systems In $6.5B TransactionFriday, October 10, 2008 @ 6:08AMEli Lilly and Company and ImClone Systems Inc. recently announced that the boards of directors of both companies have approved a definitive merger agreement under which Lilly will acquire ImClone through an all cash tender offer of $70.00 per share, or approximately $6.5B.

Eli Lilly to buy ImClone for more than $6BMonday, October 6, 2008 @ 12:17PM(AP:INDIANAPOLIS) Eli Lilly & Co. has agreed to spend more than $6 billion to fortify its cancer treatment portfolio by acquiring the biotechnology firm ImClone Systems Inc. in a deal that tops earlier offers from competitor Bristol-Myers Squibb Co.

Lilly To Buy ImCloneMonday, October 6, 2008 @ 10:32AMIndianapolis-based drug-maker Eli Lilly & Co. says it has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand its pipeline of cancer treatments.

Eli Lilly agrees to buy ImClone for over $6BMonday, October 6, 2008 @ 9:28AMNEW YORK - The drugmaker Eli Lilly & Co. said Monday it has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand its pipeline of cancer treatments.

Eli Lilly agrees to buy ImClone for over $6BMonday, October 6, 2008 @ 9:19AMThe drugmaker Eli Lilly & Co. said Monday it has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand its pipeline of cancer treatments. New York-based ImClone had previously rejected as too low two lower-priced takeover offers from Bristol-Myers Squibb Co., its marketing partner for the cancer drug Erbitux. Indianapolis-based Lilly said ...

Lilly to acquire ImCloneMonday, October 6, 2008 @ 9:09AMLilly expects the $6 billion deal would expand its pipeline of cancer treatments.

Eli Lilly agrees to buy ImClone for over $6BMonday, October 6, 2008 @ 8:54AMNEW YORK - The drugmaker Eli Lilly & Co. said Monday it has agreed to buy biotechnology company ImClone Systems Inc. for more than US$6 billion in a deal that would expand its pipeline of cancer treatments.

Eli Lilly to buy ImClone for more than $6BMonday, October 6, 2008 @ 8:34AMEli Lilly & Co. has agreed to spend more than $6 billion to fortify its cancer treatment portfolio by acquiring the biotechnology firm ImClone Systems Inc. in a deal that tops earlier offers from competitor Bristol-Myers Squibb Co. Indianapols-based Lilly announced Monday that it will pay $70 per share for ImClone. New York-based Bristol-Myers then said it would not increase its latest offer ...